PROCLAIM: Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart Failure
Completed · Phase 2 · Has a placebo group
Conditions studied: Congestive Heart Failure
In brief
This Phase 2, randomized, placebo-controlled, multicenter outpatient study is designed to test the safety and tolerability of AC2592 as well as examine the effect of AC2592 on oxygen consumption during maximal tolerated exercise in adult subjects with chronic congestive heart failure.
Key facts
- Study ID
- NCT00099580
- Run by
- AstraZeneca
- People needed
- 61
- Starts
- 2005-03-01
- Expected to finish
- 2006-09-01
- Last updated by the study team
- 2015-01-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Beverly Hills, California, United States
- Research Site — Mission Viejo, California, United States
- Research Site — New Haven, Connecticut, United States
- Research Site — Washington D.C., District of Columbia, United States
- Research Site — Jacksonville, Florida, United States
- Research Site — Tampa, Florida, United States
- Research Site — Peoria, Illinois, United States
- Research Site — Springfield, Illinois, United States
- Research Site — Winfield, Illinois, United States
- Research Site — Wichita, Kansas, United States
- Research Site — Baton Rouge, Louisiana, United States
- Research Site — Shreveport, Louisiana, United States
- Research Site — Auburn, Maine, United States
- Research Site — Boston, Massachusetts, United States
- Research Site — Detroit, Michigan, United States
- Research Site — Lincoln, Nebraska, United States
- Research Site — Chapel Hill, North Carolina, United States
- Research Site — Durham, North Carolina, United States
- Research Site — Cincinnati, Ohio, United States
- Research Site — Cleveland, Ohio, United States
- Research Site — Columbus, Ohio, United States
- Research Site — Oklahoma City, Oklahoma, United States
- Research Site — Medford, Oregon, United States
- Research Site — Portland, Oregon, United States
- Research Site — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.